Cardior Pharmaceuticals - a Novo Nordisk company
@CardiorPharmaCardior is a leading clinical-stage biopharmaceutical company pioneering RNA-based therapeutics designed to address the root causes of cardiac dysfunction.
Similar User
@ThomasThum_TH2
@InstCardReg_FFM
@StefanieDimmel1
@Thum_Lab
@ChristophMaack
@BrandesLab
@Ralf_P_Brandes
@LarsMaeg
@gabrieleschiat1
@JanaGrune
@Ralf_Gilsbach
@monamalekmoh
Our CEO, @ClaudiaUlbrich_ will join a panel at HQ Trust Investors Forum 2024 during Euro Finance Week. She’ll share insights on Cardior’s recent acquisition by Novo Nordisk as an example of adding impact to returns for investing into innovation. #EuroFinanceWeek #HQTrustForum
Our CEO, Dr. Claudia Ulbrich, and CSO/CMO Dr. Thomas Thum will be engaging in key discussions on the future of healthcare with global leaders across the industry. If you're attending, let’s connect! #FallingWalls #ScienceSummit24
We are excited that Cardior Pharmaceuticals' CEO and Co-Founder Dr. Claudia Ulbrich is invited to speak at BioMed Life Science Day organized by BioMed Partners in Basel, Switzerland on October 31, 2024.
Cardior Pharmaceuticals’ CEO and Co-Founder Dr. Claudia Ulbrich is in Oslo this week to take part in Hadean Investment Event 2024 organized by #Hadeanventures held in the world famous #Munchmuseeum on October 23-24.
Dr. Sandor Batkai, @CardiorPharma's Co-founder & Head of Medical Research and Intelligence, is presenting at the 3rd Annual Heart Failure Drug Discovery & Development Summit in Boston, MA on Aug 1, 2024. Check the agenda for more and stop by: heartfailuresummit.com
We congratulate Vicente Godoy on the promotion to Vice President Quality Management & Compliance and welcome him to @CardiorPharma Leadership Team!
We are happy to announce @ThomasThum_TH2 and Dr. @ClaudiaUlbrich_ are among the finalists of Andreas & Thomas Struengmann Award, the first of its kind in the DACH region aimed at recognizing entrepreneurial achievements in the life sciences arena: businesswire.com/news/home/2024…
@CardiorPharma CEO Dr. @ClaudiaUlbrich_ is participating in @DemiColton Biotech CEO Summit Europe in Barcelona, Spain on May 27-29, 2024. On Monday May 27 Claudia is invited to speak at Fireside Chat moderated by @PKOZA of Blue Matter. To learn more: biotechceosummit-eu.com/2024-program/
Cardior’s founder and CSO/CMO Prof. @ThomasThum_TH2 will present the exciting journey starting from research on #microRNAs at the bench to clinical testing in heart failure and the potential of #CDR132L to tackle the root causes of acute and chronic HF: escardio.org/Congresses-Eve…
Here’s a teaser to a new episode from Hannover 🇩🇪 with Claudia Ulbrich, CEO and co-founder of @CardiorPharma Hear the details about Cardior’s recent €1B exit to @novonordisk, miRNA/Cardiovascular and more. Watch on YouTube, Spotify or Apple. What do you think? 🤔
Watch our CEO, @ClaudiaUlbrich_, in the @Flotbio podcast where she discussed the recent €1B acquisition of Cardior by @novonordisk . The episode is a deep dive into @CardiorPharma story and acquisition and the inspiring career of Dr. Claudia Ulbrich: youtube.com/watch?v=yxCw5R…
As of May 2, 2024 @CardiorPharma has become a fully owned subsidiary of @novonordisk Happy to combine forces with Novo Nordisk to accelerate the clinical development of our lead compound with the aim of bringing life-saving treatment to heart patients! Two teams in Hannover.
@CardiorPharma's CEO Dr. @ClaudiaUlbrich_ is participating in German Biotech Days 2024 taking place in Berlin on April 16-17. It is the best place to feel the pulse of German biotech and a perfect meeting point for science and business.
On Wednesday April 17 @ThomasThum_TH2, Professor of @MHH_life and @CardiorPharma's CSO/CMO is holding a presentation on the development of noncoding #RNA therapeutics for #CDV at @KeystoneSymp Cardiovascular Epigenetics and Gene Regulation. Learn more: keystonesymposia.org/conferences/co…
Huge thanks from the @CardiorPharma team to all of you, our partners and friends, for your heartfelt congratulations on the potential acquisition by @novonordisk It’s an important step towards bringing #RNA-based therapies to heart failure patients! More cardior.de/media/
We are extremely excited to share that @novonordisk agreed to acquire @CardiorPharma for up to €1.025 billion. With Novo, we have found the ideal partner to accelerate the clinical development of lead compound CDR132L which is in Phase 2 in heart failure. bit.ly/3TNAdgI
Tomorrow at 12:37 CET Professor @ThomasThum_TH2 is speaking on “Clinical development of small #RNA therapeutics” at the 9th German Pharm-Tox Summit in Munich, Germany. The Summit is also held online. More in the program: programme.conventus.de/en/gpts-2024/p…
Dr. Sandor Batkai, @CardiorPharma's Head of Medical Research and Intelligence will be an expert panelist and will hold a presentation on #microRNA therapeutics in #heartfailure at #Biologics2024. Check the Agenda for details and stop by: oxfordglobal.com/biologics/even…
Today we celebrate #women’s achievements but also raise awareness about inequality women face in different domains of life including health: #cardiovascular diseases in women remain understudied, undertreated and women are underrepresented in clinical trials.#InspireInclusion
Happy heart is healthy heart As everybody is posting hearts today, we put up #CDR132L Mode of Action Video on our webpage cardior.de The video explains the mechanism of action of our lead candidate and shows its healing effects on the heart. Happy Valentine❤️❤️
United States Trends
- 1. Chargers 41,2 B posts
- 2. Bengals 48,4 B posts
- 3. Herbert 26,2 B posts
- 4. Joe Burrow 10,8 B posts
- 5. #BaddiesMidwest 15,7 B posts
- 6. Chiefs 150 B posts
- 7. #CINvsLAC 6.801 posts
- 8. Josh Allen 64,6 B posts
- 9. Bills 160 B posts
- 10. Zac Taylor 2.654 posts
- 11. McPherson 2.136 posts
- 12. WWIII 143 B posts
- 13. Russia 722 B posts
- 14. #WhoDey 1.422 posts
- 15. #SNFonNBC N/A
- 16. Harbaugh 12,6 B posts
- 17. #BoltUp 3.113 posts
- 18. 49ers 44,6 B posts
- 19. Money Mac N/A
- 20. Super Bowl 6.031 posts
Who to follow
-
Thomas Thum
@ThomasThum_TH2 -
Institute of CVR
@InstCardReg_FFM -
Stefanie Dimmeler
@StefanieDimmel1 -
Thum Lab
@Thum_Lab -
Christoph Maack
@ChristophMaack -
Institute for Cardiovascular Physiology
@BrandesLab -
Ralf Brandes
@Ralf_P_Brandes -
Lars Maegdefessel
@LarsMaeg -
Gabriele G. Schiattarella
@gabrieleschiat1 -
Jana Grune
@JanaGrune -
Ralf Gilsbach
@Ralf_Gilsbach -
Mona Malek Mohammadi
@monamalekmoh
Something went wrong.
Something went wrong.